These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27989858)

  • 1. Aerosolizable modified-release particles of montelukast improve retention and availability of the drug in the lungs.
    Patel B; Rashid J; Ahsan F
    Eur J Pharm Sci; 2017 Jan; 96():560-570. PubMed ID: 27989858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Molecular-Weight Heparin-Coated and Montelukast-Filled Inhalable Particles: A Dual-Drug Delivery System for Combination Therapy in Asthma.
    Patel B; Rashid J; Gupta N; Ahsan F
    J Pharm Sci; 2017 Apr; 106(4):1124-1135. PubMed ID: 28057540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model.
    Patel B; Gupta N; Ahsan F
    Pharm Res; 2014 Nov; 31(11):3095-105. PubMed ID: 24934662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).
    Rashid J; Patel B; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
    J Control Release; 2017 Mar; 250():96-106. PubMed ID: 28185800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of PEI as a core modifying agent on PLGA microspheres of PGE₁, a pulmonary selective vasodilator.
    Gupta V; Ahsan F
    Int J Pharm; 2011 Jul; 413(1-2):51-62. PubMed ID: 21530623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin.
    Patel B; Gupta V; Ahsan F
    J Control Release; 2012 Sep; 162(2):310-20. PubMed ID: 22800582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes.
    Koushik K; Dhanda DS; Cheruvu NP; Kompella UB
    Pharm Res; 2004 Jul; 21(7):1119-26. PubMed ID: 15290850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin (LMWH)-loaded large porous PEG-PLGA particles for the treatment of asthma.
    Patel B; Gupta N; Ahsan F
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):12-20. PubMed ID: 24286441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine.
    Thomas C; Rawat A; Hope-Weeks L; Ahsan F
    Mol Pharm; 2011 Apr; 8(2):405-15. PubMed ID: 21189035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization.
    Ni R; Muenster U; Zhao J; Zhang L; Becker-Pelster EM; Rosenbruch M; Mao S
    J Control Release; 2017 Mar; 249():11-22. PubMed ID: 28109773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
    Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
    J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility study of aerosolized prostaglandin E1 microspheres as a noninvasive therapy for pulmonary arterial hypertension.
    Gupta V; Rawat A; Ahsan F
    J Pharm Sci; 2010 Apr; 99(4):1774-89. PubMed ID: 19894275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses.
    Thomas C; Gupta V; Ahsan F
    Int J Pharm; 2009 Sep; 379(1):41-50. PubMed ID: 19524654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large Porous Particles for Sustained Release of a Decoy Oligonucelotide and Poly(ethylenimine): Potential for Combined Therapy of Chronic Pseudomonas aeruginosa Lung Infections.
    d'Angelo I; Perfetto B; Costabile G; Ambrosini V; Caputo P; Miro A; d'Emmanuele di Villa Bianca R; Sorrentino R; Donnarumma G; Quaglia F; Ungaro F
    Biomacromolecules; 2016 May; 17(5):1561-71. PubMed ID: 27002689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NanoCipro encapsulation in monodisperse large porous PLGA microparticles.
    Arnold MM; Gorman EM; Schieber LJ; Munson EJ; Berkland C
    J Control Release; 2007 Aug; 121(1-2):100-9. PubMed ID: 17604870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation.
    Nadeem A; Obiefuna PC; Wilson CN; Mustafa SJ
    Eur J Pharmacol; 2006 Dec; 551(1-3):116-24. PubMed ID: 17027749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis.
    Zamani M; Prabhakaran MP; Varshosaz J; Mhaisalkar PS; Ramakrishna S
    Acta Biomater; 2016 Sep; 42():316-328. PubMed ID: 27397493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.